Lara Magro

Lara Magro

Auto-generated profile, based on publicly available information

Lara Magro

University of Verona

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 October 2011 in Expert Opinion on Drug Safety
Verified
Journal Article
Closed access
LMLara Magro
Lara Magro
UMUgo Moretti
Ugo Moretti
RLRoberto Leone
Roberto Leone
Introduction: Drug–drug interactions (DDIs) arise in numerous different ways, involving pharmacokinetic or pharmacodynamic mechanisms. Adverse drug reactions are a possible consequence of DDIs and health operators are often unaware of the clinical risks of certain drug combinations. Many papers on drug interactions have been published in recent years, but most of them focused on potential DDIs while few studies have been conducted on actual interactions. Areas covered: This paper reviews the epidemiology of actual DDIs in outpatients as well as in hospital settings and in spontaneous reporting databases. The incidence of actual DDIs is consistently lower than that of potential DDIs. However, the absolute number of patients involved is high, representing a significant proportion of adverse drug reactions. The importance of risk factors such as age, polypharmacy and genetic polymorphisms is also evaluated. The relevance and efficacy of tools for recognizing and preventing DDIs are discussed. Expert opinion:...

1 April 2004 in Journal of Pharmaceutical and Biomedical Analysis
Verified
Journal Article
Closed access
Federica PellatiFederica Pellati
Federica Pellati
SBstefania benvenuti
stefania benvenuti
LMLara Magro
Lara Magro
MMMichele Melegari
Michele Melegari
FSFabrizia Soragni
Fabrizia Soragni

1 August 2010 in Drug Safety
Verified
Journal Article
Closed access
PDF file
RLRoberto Leone
Roberto Leone
LMLara Magro
Lara Magro
UMUgo Moretti
Ugo Moretti
PCPaola Cutroneo
Paola Cutroneo
MMMartina Moschini
Martina Moschini
ACAnita Conforti
Anita Conforti

9 March 2013 in Drug Safety
Verified
Journal Article
Closed access
PDF file
RLRoberto Leone
Roberto Leone
UMUgo Moretti
Ugo Moretti
PDPaola D’iNcau
Paola D’iNcau
ACAnita Conforti
Anita Conforti
LMLara Magro
Lara Magro
GVGiampaolo Velo
Giampaolo Velo

17 October 2009 in European Journal of Clinical Pharmacology
Verified
Journal Article
Closed access
PDF file
CPCarlo Piccinni
Carlo Piccinni
CSChiara Sacripanti
Chiara Sacripanti
EPElisabetta Poluzzi
Elisabetta Poluzzi
DMDomenico Motola
Domenico Motola
LMLara Magro
Lara Magro
NMNicola Montanaro
Nicola Montanaro

29 August 2014 in Expert Opinion on Drug Safety
Verified
Journal Article
Closed access
EPElisabetta Parretta
Elisabetta Parretta
CRConcetta Rafaniello
Concetta Rafaniello
LMLara Magro
Lara Magro
APAnna Coggiola Pittoni
Anna Coggiola Pittoni
LSLiberata Sportiello
Liberata Sportiello
ACAnnalisa Capuano
Annalisa Capuano
Adverse drug reaction (ADR) reporting by patients has a fundamental role in pharmacovigilance. The main objectives of the present study were to assess the impact of a pharmacist-based intervention in promoting direct patient reporting, to evaluate patient ability to identify and report ADRs and to determine their pattern. The study involved 96 pharmacists in the Campania region of Italy, who interviewed their customers and asked them whether they had experienced an ADR. Patients who had experienced an ADR were invited to complete an ADR reporting form. The quality of completed ADR reporting forms was evaluated before their entry into the Italian Spontaneous Reporting System (Rete Nazionale di Farmacovigilanza [RNF]) and, once entered, their pattern was determined. A total of 18,677 patients were interviewed, and 10.88% had experienced an ADR. After quality control, 54.32% of all reporting forms were entered into the RNF so that patient contribution to spontaneous reporting, null over the years, reached ∼7%. Patients reported mainly non-serious (91.28%) and expected (94.62%) ADRs, and NSAIDs or antibiotics were the most frequently reported drugs. The study shows that pharmacists can have an important role in promoting patient reporting and adds new information on how a patient reporting form should be structured.